Financial Results – Page 18

  • Article

    Alcon’s first year after Novartis spin-off is a success

    2020-04-05T13:21:00Z

    Alcon reported total sales of $7,362 million for the full year 2019, an increase of 3 percent on a reported basis and 5 percent in constant currencies. The management said that 2019 was a good year for the company, as it completed its spin-off from Novartis to become an ...

  • Article

    Lawsuit widens Bausch Health’s net loss in Q4

    2020-04-05T13:20:00Z

    Bausch Health reported a net loss of $1,516 million for the fourth quarter, compared with a net loss of $344 million for the year-ago period. The management blamed mainly the accrual of legal reserves established for the resolution of a so-called “stock drop” litigation in the U.S. linked to the ...

  • Article

    EssilorLuxottica posts strong sales and profits for 2019

    2020-04-04T19:38:00Z

    In 2019, the first full year in which Essilor and Luxottica were part of the same company, EssilorLuxottica – alias Essilux – enjoyed a 7.4 percent jump in revenues to €17.390 million on a pro-forma basis. In constant currencies, they grew by 4.4 percent. One of the highlights was a ...

  • Article

    CooperVision grows by 4% in Q1

    2020-04-02T09:00:00Z

    CooperVision’s sales went up by 3 percent to $485.2 million in the first quarter of Cooper Companies’ financial year, which ended on Jan. 31, and its gross margin improved by 0.5 percentage points to 66.5 percent. Sales of toric lenses rose by 6 percent to $155.1 million, multifocal lenses ...

  • Article

    Safilo continues to produce despite harsher lockdown measures

    2020-04-02T09:00:00Z

    As its core business consists of making “medical devices,” Safilo has continued manufacturing both prescription frames and sunglasses in Italy despite harsher governmental regulations for the lockdown of non-essential activities in the country to stop the propagation of the Covid-19 virus. We could not determine at press time how many ...

  • Article

    GrandVision issues profit warning due to Covid-19

    2020-04-02T09:00:00Z

    Because of the Covid-19 pandemic, GrandVision (GV) no longer expects this year to achieve its medium-term objectives of an annual growth of at least 5 percent in revenue and Ebita. It noted that the business environment remains uncertain but the company is confident that it will complete its takeover by ...